The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Aww damn won't let me add link :(
This is what I'm talking about... SALVARX owns stake in therapeutics and the boom begins :) http://www.businesswire.com/news/home/20160628005076/en/Intensity-Therapeutics-Raises-10-Million-Fund-Clinical
Bargain price! brilliant people on board with fantastic backgrounds! Grab a slice at this price!
The RNS is actually a very positive one. There is no fundamental reason for the drop as far as progress of Salvarx is concerned. The drop is down to the uncertainties following the referendum which has spooked the markets generally. SALV still offers a fantastic opportunity however to be a part of the $80 billion market for immunotherapy drugs, whilst improving the outcome of millions of cancer patients worldwide.
looks like the market have not reacted well to this rns ??? down to 24p ..... hum..... what are peoples views on this drop ?
We could really do with an update soon as RNSs have been a bit thin on the ground lately. SALV has enormous potential but news flow is important to maintain investor interest.
This is well worth a watch. https://www.youtube.com/watch?v=68V0KbSXM0s you will do well to find a company on Aim with just a strong team behind it.
Therapeutics http://www.dailymail.co.uk/news/article-3577432/Vaccine-breakthrough-cure-cancer-stop-returning.html
..recently join on BOD, what a wonderful leaderships...!!!
Yes very positive indeed :-) This is my favourite bit from the interview. Are goal is to develop a robust data package that would form the basis for discussion with bigger pharma company's, we have already had interest from several company's already. Salv has a clear plan going forward, and the right people backing it, few shares in free float, hard not to see this trading in the £££££ in the not so distant future. ATB Jay
Great find Jay. Thanks for posting. Post Recommended. All sounds very positive to me. Time to start accumulating I think. This could be massive, IMO of course. Further reading... http://www.proactiveinvestors.co.uk/companies/news/125503 Comparison companies in the US include Kite and Juno according to JM many moons ago. Whilst acknowledging that they are both well established and as yet we are not, they are both huge companies! Good Luck
Good spot JayMonk thanks for the link
Says SalvaRx boss. https://www.youtube.com/watch?v=EVWVYZN1f64
Investment in Intensity Therapeutics Inc and Convertible Loan Note SalvaRx (LON: SALV), a biotechnology company focused on immunotherapy for cancer, is today pleased to announce its investment in US-based Intensity Therapeutics Inc. ("Intensity"), a private biotechnology company pioneering a new approach to treating solid tumours. The Company has invested US$2 million in cash for a 9.2% interest in Intensity ("the Investment") as part of a Series A funding round....
Another step in the right direction :-)
Grant funding from the European Commission for a new product SalvaRx (LON: SALV), a biotechnology company focused on immunotherapy for cancer, is pleased to announce that an international multi-disciplinary consortium of 11 academic and commercial partners, including its subsidiary, iOx Therapeutics Ltd. ("iOx"), has received an €8.3 million Horizon 2020 grant to support the development of new immunotherapy candidates. iOx will benefit directly as one of the candidates being developed is a new combination product based on one of its compounds. In addition, iOx will be able to reclaim €150,000 of its development costs associated with the new product......
Shame so quiet here at the moment. I cant wait for the first decent RNS :)
Meant SAR
over to Sav, so I grabbed some on the dip, if you look at sav shares in issue compare to salv, then just imagine what a good RNS will do, very few free float here. ATB Jay
There are only 4 clinical trials for T cell research active at the moment, on of them is a company called Adaputimmune This company will ipo at a value of 1.1bln$. Now there is a reason that 80% of the company is owned by 3 ppl. How many companies in aim have such a tight share register. We have funding, we have a head start in the trails, anyone looking at getting into TCell reaserch will be looking at Salv. Some of the placing stock is held my brokers who were looking to flip in the first week. They have had to settle or roll their positions. They will not be holding long term. Once this stock is bought by lth stock will dry up the so will go up. Who would sell. Good luck guys. And to those who have been in a long time. Hold tight things have changed, it's going to be big very big.
I watched this yesterday, I am very excited about this stock!!!
Just in case you wondered why you are invested, do you have enough stock, should I be looking for a bottom. This is massive at Goldman Sachs who are literal market movers Enjoy goldmansachs.com/our-thinking/t…
I'm happy to be in here early and will continue to add into next years isa along the way.
signs in the early days of this stock. However, given the potential of this stock, the big hitters involved, and the newsflow to come, it will be at least 80p before I even start thinking about de-risking anything. Even then I'd have to consider it. Very bullish on this for the years to come.